Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,071 | 51,095 | 11,041 | 6,674 | 8,363 |
| Other current assets | 897 | 841 | 532 | 704 | 117 |
| TOTAL | $49,968 | $51,936 | $11,573 | $7,378 | $8,480 |
| Non-Current Assets | |||||
| PPE Net | 21 | 10 | 12 | 10 | 10 |
| Other Non-Current Assets | 440 | 36 | 48 | 73 | 46 |
| TOTAL | $461 | $46 | $60 | $83 | $56 |
| Total Assets | $50,429 | $51,982 | $11,633 | $7,461 | $8,536 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,773 | 761 | 576 | 167 | 418 |
| Accrued Expenses | 1,726 | 766 | 752 | 988 | 508 |
| TOTAL | $3,499 | $1,527 | $1,328 | $1,155 | $926 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 409 | 0 | 0 | 0 | 0 |
| TOTAL | $409 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,908 | $1,527 | $1,328 | $1,155 | $926 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,200 | 776 | 492 | 133 | 133 |
| Common Shares | 10 | 9 | 2 | 2 | 2 |
| Retained earnings | -154,154 | -149,029 | -147,038 | -145,736 | -144,416 |
| TOTAL | $46,521 | $50,455 | $10,305 | $6,306 | $7,610 |
| Total Liabilities And Equity | $50,429 | $51,982 | $11,633 | $7,461 | $8,536 |